Clinical Trial Update: Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations [Phase 4]

View source ↗

Summary

Phase 4 study update evaluating adverse drug reactions of apatinib and their biomarker correlations in Stage IV cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Stage IV Cancer | Phase 4 | Status: UNKNOWN